Open Orphan distribution in specie shares and in particular some people had been concerned that they were unable to trade them.
Open Orphan plc distribution in specie of Poolbeg Pharma plc shares – Q&A
Open Orphan PLC (AIM:ORPH) Trading Update and screening facilities expansion
Volunteer Recruitment and Laboratory Facilities Expansion
Open Orphan PLC (AIM: ORPH) Appointment of Chief Executive Officer
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces the
Open Orphan PLC (AIM: ORPH) FDA Breakthrough Designation for Big Pharma RSV
Vaccine candidate assessed in successful human challenge trial conducted by hVIVO
Open Orphan PLC (AIM: ORPH) Positive results from RSV Human Challenge Study
Data on Phase 2a study published in New England Journal of Medicine
Open Orphan plc (AIM: ORPH) Launch of STRiVE project
Respiratory viral strains suitable for challenge agents being collected from consenting volunteers
Open Orphan PLC (ORPH.L) World’s first COVID-19 Characterisation Study
Results from the world’s first COVID-19 Characterisation Study Data shows SARS-CoV-2 human challenge studies are safe in healthy young adults
Open Orphan PLC (ORPH.L) Malaria Human Challenge Model Launched
First volunteers inoculated with Malaria human challenge virus
Open Orphan PLC (ORPH.L) £5m Influenza human challenge study contract win
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials , announces that hVIVO
Open Orphan PLC (ORPH.L) $13.4m Influenza human challenge study contract win
Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and antiviral testing using human challenge clinical trials, announces that hVIVO, a
Open Orphan PLC (ORPH.L) Positive results from Flu Human Challenge Study
Positive results from Influenza Human Challenge Study conducted by hVIVO
